Auteurs
Checkpoint
Pmc
Racine
Checkpoint
Pmc
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Pmc)

Index « Auteurs » - entrée « Yoshiya Tanaka »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Yoshitsugu Miyazaki < Yoshiya Tanaka < Yoshiyuki Kojima  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000015 (2020) Gulzhan Trimova ; Kaoru Yamagata ; Shigeru Iwata ; Shintaro Hirata [Japon] ; Tong Zhang ; Fumi Uemura ; Minoru Satoh [Japon] ; Norma Biln ; Shingo Nakayamada ; Walter P. Maksymowych ; Yoshiya TanakaTumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages
000100 (2020) Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Sakae Tanaka [Japon] ; Atsushi Kawakami [Japon] ; Yeong-Wook Song [Corée du Sud] ; Yi-Hsing Chen [Taïwan] ; Mitsuhiro Rokuda [Japon] ; Hiroyuki Izutsu [Japon] ; Satoshi Ushijima [Japon] ; Yuichiro Kaneko [Japon] ; Yoshihiro Nakashima [Japon] ; Teruaki Shiomi [Japon] ; Emi Yamada [Japon]Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan
000220 (2020) Sae Ochi [Japon] ; Kazuyoshi Saito [Japon] ; Fumitaka Mizoguchi [Japon] ; Shigeaki Kato [Japon] ; Yoshiya Tanaka [Japon]Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study
000407 (2020) Takahiko Sugihara [Japon] ; Hitoshi Hasegawa ; Haruhito A. Uchida [Japon] ; Hajime Yoshifuji [Japon] ; Yoshiko Watanabe [Japon] ; Eisuke Amiya [Japon] ; Yasuhiro Maejima [Japon] ; Masanori Konishi [Japon] ; Yohko Murakawa [Japon] ; Noriyoshi Ogawa [Japon] ; Shunsuke Furuta [Japon] ; Yasuhiro Katsumata [Japon] ; Yoshinori Komagata [Japon] ; Taio Naniwa [Japon] ; Takahiro Okazaki [Japon] ; Yoshiya Tanaka [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshikazu Nakaoka [Japon] ; Yoshihiro Arimura [Japon] ; Masayoshi Harigai [Japon] ; Mitsuaki Isobe [Japon]Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions
000776 (2019) Desirée Van Der Heijde [Pays-Bas, Norvège] ; Michael Schiff [États-Unis] ; Yoshiya Tanaka [Japon] ; Li Xie [États-Unis] ; Gabriella Meszaros [États-Unis] ; Taeko Ishii [États-Unis] ; Marta Casillas [États-Unis] ; Robert A. Ortmann [États-Unis] ; Paul Emery [Royaume-Uni]Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis
000909 (2019) Yuya Fujita [Japon] ; Masao Nawata [Japon] ; Atsushi Nagayasu [Japon] ; Kazuki Someya [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon]Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report
000942 (2019) Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Sakae Tanaka [Japon] ; Atsushi Kawakami [Japon] ; Manabu Iwasaki [Japon] ; Kou Katayama [Japon] ; Mitsuhiro Rokuda [Japon] ; Hiroyuki Izutsu [Japon] ; Satoshi Ushijima [Japon] ; Yuichiro Kaneko [Japon] ; Teruaki Shiomi [Japon] ; Emi Yamada [Japon] ; Désirée Van Der Heijde [Pays-Bas]Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan
000D88 (2017) Stanley B. Cohen [États-Unis] ; Yoshiya Tanaka [Japon] ; Xavier Mariette [France] ; Jeffrey R. Curtis [États-Unis] ; Eun Bong Lee [Corée du Sud] ; Peter Nash [Australie] ; Kevin L. Winthrop [États-Unis] ; Christina Charles-Schoeman [États-Unis] ; Krishan Thirunavukkarasu [Australie] ; Ryan Demasi [États-Unis] ; Jamie Geier [États-Unis] ; Kenneth Kwok [États-Unis] ; Lisy Wang [États-Unis] ; Richard Riese [États-Unis] ; Jürgen Wollenhaupt [Allemagne]Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials
001136 (2012) Josef S. Smolen [Autriche] ; Monika M. Schoels [Autriche] ; Norihiro Nishimoto [Japon] ; Ferdinand C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Cem Gabay [Suisse] ; Allan Gibofsky [États-Unis] ; Juan Jesus Gomez-Reino [Espagne] ; Graeme Jones [Australie] ; Tore K. Kvien [Norvège] ; Miho Murakami [Japon] ; Neil Betteridge [Royaume-Uni] ; Clifton O. Bingham [États-Unis] ; Vivian Bykerk [Suisse] ; Ernest H. Choy [Royaume-Uni] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Winfried Graninger [Autriche] ; Angel Lanas [Espagne] ; Emilio Martin-Mola [Espagne] ; Carlomaurizio Montecucco [Italie] ; Mikkel Ostergaard [Danemark] ; Karel Pavelka [République tchèque] ; Andrea Rubbert-Roth [Allemagne] ; Naveed Sattar [Royaume-Uni] ; Marieke Scholte-Voshaar [Suisse] ; Yoshiya Tanaka [Japon] ; Michael Trauner [Autriche] ; Gabriele Valentini [Italie] ; Kevin L. Winthrop [États-Unis] ; Maarten De Wit [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas]Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
001149 (2011) Takao Koike [Japon] ; Masayoshi Harigai [Japon] ; Shigeko Inokuma [Japon] ; Naoki Ishiguro [Japon] ; Junnosuke Ryu [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Hisashi Yamanaka [Japon] ; Koichi Fujii [Japon] ; Takunari Yoshinaga [Japon] ; Bruce Freundlich [États-Unis] ; Michio Suzukawa [Japon]Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Pmc/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/Author.i -k "Yoshiya Tanaka" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/Author.i  \
                -Sk "Yoshiya Tanaka" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Yoshiya Tanaka
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021